Nephrol Dial Transplant (2000) 15: 2007-2013
© 2000 European Renal Association-European Dialysis and Transplant Association
Intervention thresholds and ceilings can determine the haemoglobin outcome distribution in a haemodialysis population
Department of Renal Medicine, St James's University Hospital, Leeds, UK
We have explored the consequences of setting different thresholds and ceilings for erythropoietin dose changes in two randomized controlled studies of renal anaemia management based on an established algorithm.
Study 1. A large (n=236) unselected haemodialysis cohort was randomized to monthly intervention (increased erythropoietin (Epo)) at haemoglobin (Hb) levels falling below either 10.5 g/dl (group A) or 11.5 g/dl (group B) and followed for 6 months. The mean Hb was 0.6 g/dl higher in the 11.5 g/dl threshold group (11.1 g/dl vs 11.7 g/dl) at 6 months (P=0.001++). The Epo dose did not differ between them (median 133 IU/kg/week, Interquartile range (IQR) 86217 and 140, IQR 74227 respectively) (P=NS**).
Study 2. A large (n=211) unselected haemodialysis cohort was randomized to a reduction in Epo dose at Hb levels above either 12.0 g/dl (group C) or 13.0 g/dl (group D). The Hb outcome at 8 months differed between group C (mean 11.5 g/dl, SD 1.4) and group D (12.2, SD 2.1) (P=0.03++). The Epo dose did not significantly differ between groups C and D (median 60 IU/kg/week, IQR 32142 and 71, IQR 38117 respectively) (P=NS**).
Study 1 showed that an intervention threshold of 11.0 g/dl with a mean Hb outcome of 11.6 g/dl and SD 1.6 g/dl would produce the desired UK Renal Association Standards outcome of 85% Hb
10.0 g/dl. Study 2 demonstrated that a ceiling of 12.0 g/dl narrowed the range of Hb values (P<0.001##), achieving a SD of 1.37 g/dl, and reduced the number of patients with a Hb >13.0 g/dl from 25 to 12%. This narrowing of the distribution has cost implications for reaching minimum standards in a haemodialysis population. Formal use of threshold and ceiling values for intervention within an anaemia management system enabled the haemodialysis population outcome mean and SD to be literally prescribed.
Keywords: haemodialysis; haemoglobin; intervention; outcome; thresholds
Correspondence and offprint requests to: Dr Donald Richardson, Renal Research Registrar, St James's University Hospital, Beckett Street, Leeds LS9 7TF, UK.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. L. M. de Francisco, P. Stenvinkel, and S. Vaulont Inflammation and its impact on anaemia in chronic kidney disease: from haemoglobin variability to hyporesponsiveness NDT Plus, January 1, 2009; 2(suppl_1): i18 - i26. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Brimble and C. M. Clase Hemoglobin Variability in Dialysis Patients J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2218 - 2220. [Full Text] [PDF] |
||||
![]() |
R. M. West, K. Harris, M. S. Gilthorpe, C. Tolman, and E. J. Will Functional Data Analysis Applied to a Randomized Controlled Clinical Trial in Hemodialysis Patients Describes the Variability of Patient Responses in the Control of Renal Anemia J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2371 - 2376. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Carrera Foreword Nephrol. Dial. Transplant., June 1, 2007; 22(suppl_4): iv1 - iv1. [Full Text] [PDF] |
||||
![]() |
P. Barany and H.-J. Muller Maintaining control over haemoglobin levels: optimizing the management of anaemia in chronic kidney disease Nephrol. Dial. Transplant., June 1, 2007; 22(suppl_4): iv10 - iv18. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Will, D. Richardson, C. Tolman, and C. Bartlett Development and exploitation of a clinical decision support system for the management of renal anaemia Nephrol. Dial. Transplant., June 1, 2007; 22(suppl_4): iv31 - iv36. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Tolman, D. Richardson, C. Bartlett, and E. Will Structured Conversion from Thrice Weekly to Weekly Erythropoietic Regimens Using a Computerized Decision-Support System: A Randomized Clinical Study J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1463 - 1470. [Abstract] [Full Text] [PDF] |
||||
![]() |
E J Will Aiming at averages J R Soc Med, January 12, 2001; 94(12): 617 - 619. [Full Text] [PDF] |
||||



